P489 How often is dose escalation needed in patients with inflammatory bowel disease treated with anti-TNF?

Autor: Viazis, N., Koukouratos, T., Saprikis, E., Al-Odat, M., Anastasopoulos, E., Zacharakis, G., Karamanolis, D.
Zdroj: In Journal of Crohn's and Colitis February 2013 7 Supplement 1:S206-S206
Databáze: ScienceDirect